HOUSEMARK PHARMACEUTICAL PRODUCTS

Brand Owner (click to sort) Address Description
ONCOLYTICS BIOTECH Oncolytics Biotech Inc. Suite 804, 322-11th Avenue SW Calgary, Alberta T2R0C5 Canada HOUSEMARK FOR PHARMACEUTICAL PRODUCTS; PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF CANCER;MEDICAL AND SCIENTIFIC RESEARCH, NAMELY, CONDUCTING CLINICAL TRIALS; MEDICAL AND SCIENTIFIC RESEARCH SERVICES IN THE FIELD OF CANCER TREATMENT;
ONCOLYTICS BIOTECH Oncolytics Biotech Inc. Suite 804, 322-11th Avenue SW Calgary, Alberta T2R0C5 Canada Housemark for pharmaceutical products; pharmaceutical preparations for use in the treatment of cancer;BIOTECH;
TANOX TANOX, INC. 10555 Stella Link Road Houston TX 77025 Housemark for pharmaceutical products and related services;
TANOX TANOX, INC. 10555 Stella Link Road Houston TX 77025 Housemark for pharmaceutical products and related services;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Media and processes for the fermentation of Clostridium botulinum and obtaining a botulinum toxin for use in formulating botulinum toxin pharmaceutical compositions. The growth media can contain significantly reduced levels of meat or dairy by-products using non-animal based products to replace the animal-derived products. Preferably, the media used are substantially free of animal derived products.